Evidence for the role of obesity in prostate cancer progression
– Elizabeth A. Platz, Johns Hopkins Bloomberg School of Public Health
Obesity, energy balance, and colorectal cancer survivorship
– Jeffrey Meyerhardt, Dana-Farber Cancer Institute
The impact of weight loss on cancer incidence and mortality
– Bruce M. Wolfe, Oregon Health & Science University
Correlations of obesity, comorbidity, and treatment:
– Rachel Ballard-Barbash, NCI
• What is the current state of the evidence? What are the evidence gaps?
• Is the evidence strong enough to recommend weight loss for individuals who are overweight or obese and who are either newly diagnosed with cancer or long-term cancer survivors?
• Would such an approach be recommended for all survivors or a subset of individuals diagnosed with specific cancers? If the latter, which cancers are those?
• What is the downside of recommending weight loss to cancer survivors who are overweight or obese given the high incidence of comorbidity in this population?
• What are the methodological issues for closing the evidence gaps?
• How do we adjust data on obesity for other factors such as physical activity and diet?
|11:15 am||Lunch Break
|12:15 pm||Session 2: Mechanisms by Which Obesity May Influence Cancer Progression
Moderator: Stephen Hursting, University of Texas at Austin